Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

My knee replacement

Dr Ross Walker shares his own experience of having a total knee replacement.

Series: ,
Mad about Money Live

Tune in to find out the latest money and market news with Peter Switzer and Paul Rickard.

Series: ,
We pinpoint some tech stocks you don't want to ignore!

Peter Switzer is joined by Burman Invest's Julia Lee, Medallion's Michael Wayne, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
The link between COVID-19 and heart disease

Dr Ross Walker looks at whether there is any connection between the Coronavirus and drugs used to treat cardiovascular disease.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
Is Mesoblast the biomedical stock you have to have? + Freelancer: stock on the way up?

Peter Switzer is joined by Burman Invest's Julia Lee, Freelancer.com's Matt Barrie, Vanguard's Robin Bowerman and Switzer's Paul Rickard.

Series: ,
What is a viral load?

Dr Ross Walker looks at viral load in relation to COVID-19 and which people are most at risk.

Series: ,
Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series: ,
Tech stocks on the slide! Which stocks are the best buys?

On this week's show, Peter Switzer is joined by Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
How to boost your immunity

Dr Ross Walker explains how you can boost your immunity and which vitamins will give you an extra boost.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
7 Experts! Their One Best Stock! Plus, CEO of NextDC - Check Out The Future!

Peter Switzer talks to the experts about the best companies coming out of reporting season, plus NextDC CEO Craig Scroggie.

Series: ,
1 40 41 42 43 44 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram